Diallyl trisulfide inhibits migration, invasion and angiogenesis of human colon cancer HT-29 cells and umbilical vein endothelial cells, and suppresses murine xenograft tumour growth.

Abstract

Angiogenesis inhibitors are beneficial for the prevention and treatment of angiogenesis-dependent diseases including cancer. We examined the cytotoxic, anti-metastatic, anti-cancer and anti-angiogenic effects of diallyl trisulfide (DATS). In HT29 cells, DATS inhibited migration and invasion through the inhibition of focal adhesion kinase (FAK), extracellular signal-regulated kinase, c-Jun N-terminal kinase and p38 which was associated with inhibition of matrix metalloproteinases-2, -7 and -9 and VEGF. In human umbilical vein endothelial cells (HUVEC), DATS inhibited the migration and angiogenesis through FAK, Src and Ras. DATS also inhibited the secretion of VEGF. The capillary-like tube structure formation and migration by HUVEC was inhibited by DATS. The chicken egg chorioallantoic membrane (CAM) assay indicated that DATS treatment inhibited ex-vivo angiogenesis. We investigated the anti-tumour effects of DATS against human colon cancer xenografts in BALB/c(nu/nu) mice and its anti-angiogenic activity in vivo. In this in-vivo study, DATS also inhibited the tumour growth, tumour weight and angiogenesis (decreased the levels of haemoglobin) in HT29 cells. In conclusion, the present results suggest that the inhibition of angiogenesis may be an important mechanism in colon cancer chemotherapy by DATS.

• Authors: Kuang-Chi Lai, Shu-Chun Hsu, Jai-Sing Yang, Chien-Chih Yu, Jin-Cherng Lein, Jing-Gung Chung
• Journal: Journal of cellular and molecular medicine (J Cell Mol Med) Vol. 19 Issue 2 Pg. 474-84 (Feb 2015) ISSN: 1582-4934 [Electronic] England
• PMID: 25403643 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
• Copyright: © 2014 The Authors. Journal of Cellular and Molecular Medicine published by John Wiley & Sons Ltd and Foundation for Cellular and Molecular Medicine.

Chemical References

• Allyl Compounds
• Angiogenesis Inhibitors
• Sulfides
• diallyl trisulfide

Topics

• Allyl Compounds (pharmacology)
• Angiogenesis Inhibitors (pharmacology)
• Animals
• Cell Line
• Cell Line, Tumor
• Cell Movement (drug effects)
• Cell Proliferation (drug effects)
• HT29 Cells
• Human Umbilical Vein Endothelial Cells (drug effects)
• Humans
• Mice
• Neoplasm Invasiveness (prevention & control)
• Neovascularization, Pathologic (drug therapy)
• Sulfides (pharmacology)
• Xenograft Model Antitumor Assays (methods)